AI assistant
Nitco Ltd. — Capital/Financing Update 2025
Apr 16, 2025
62410_rns_2025-04-16_67ad6dbe-2787-4a21-aa15-8b42ff62cfaa.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [157 x 66] intentionally omitted <==
NITCO/SE/2025-26/02 April 16, 2025
To,
| Corporate Service Department BSE Limited Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Script code:532722 |
The Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Script code:NITCO |
|---|---|
Dear Sir/Madam,
Sub: Intimation of receipt of In - Principle approval for listing of 15,68,63,000 equity shares of - Rs. 10 / issued on Preferential Basis from National Stock Exchange of India Limited and BSE Limited
We wish to inform you that National Stock Exchange of India Limited vide letter no. NSE/LIST/47186 dated April 03, 2025 and BSE Limited vide letter no. LOD/PREF/MV/FIP/58/2025-28 dated April 15, 2025 has granted In-principle approval for Listing of 15,68,63,000 equity shares of Rs. 10/- each allotted to promoter & non-promoters on a preferential basis.
The details required pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023 are enclosed as Annexure A.
Kindly take the above information on records.
Thanking You,
Yours Sincerely,
For NITCO Limited
Digitally signed by VIVEK VIVEK PRANNATH PRANNATH TALWAR TALWAR Date: 2025.04.16 16:34:23 +05'30'
Vivek Talwar Chairman & Managing Director DIN: 00043180 Encl: a/a
Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: [email protected] Website: www. nitco.in
==> picture [157 x 66] intentionally omitted <==
Annexure A
The details as required to be disclosed under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are as follows
| Sr.No | Particulars | Details |
|---|---|---|
| 1. | name of the regulatory or licensing authority; |
National Stock Exchange of India Limited (NSE) & BSE Limited (BSE) |
| 2. | brief details of the approval/license obtained/ withdrawn/ surrendered; |
In – Principle approval granted by NSE and BSE for Listing of 15,68,63,000 Equity shares of Rs. 10/- each issued onpreferential basis. |
| 3. | impact/relevance of such approval/license to the listed entity; |
Upon receipt of In - Principle approvals, the Company is permitted to list 15,68,63,000 equity shares of Rs. 10/- each on NSE & BSE. |
| 4. | withdrawal/cancellation or suspension of license/approval by the regulatory or licensing authority, with reasons for such action, estimated impact (monetary or otherwise) on the listed entity and penalty, if any; |
Not Applicable |
| 5. | period for which such approval/license is/was valid; |
As per the timelines stated in the approval letters |
| 6. | The actual impact (monetary or otherwise) along with corrective actions taken by the listed entity pursuant to the withdrawal, cancellation or suspension of the keylicense/approval |
Not Applicable |
Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: [email protected] Website: www. nitco.in